1 / 28

GIM Primary Care Conference Presentation October 25, 2006

2. Disclosure Statement. I have received research support (but no consulting or speaking fees) from the following companies that market smoking cessation medications:. SmithKline Beecham GlaxoSmithKline Elan Corporation, plc. 3. Learning Objectives. Psychiatric morbidity and cessation in t

andra
Download Presentation

GIM Primary Care Conference Presentation October 25, 2006

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. 1

    2. 2 Disclosure Statement I have received research support (but no consulting or speaking fees) from the following companies that market smoking cessation medications:

    3. 3 Learning Objectives Psychiatric morbidity and cessation in two case studies Influence of psychiatric morbidity on smoking cessation Evidence-based cessation treatment for smokers with psychiatric disorders

    4. 4 Case Studies

    5. 5 Case Studies

    6. 6 Case Studies: Smoking History

    7. 7

    8. 8

    9. 9

    10. 10

    11. 11

    12. 12 Tobacco Dependence and Mental Illness

    13. 13

    14. 14

    15. 15

    16. 16

    17. 17

    18. 18

    19. 19

    20. 20

    21. 21

    22. 22

    23. 23

    24. 24

    25. 25

    26. 26

    27. 27 Case Studies

    28. 28

More Related